248
Views
2
CrossRef citations to date
0
Altmetric
Review

Vascular endothelial damage in COPD: current functional assessment methods and future perspectives

ORCID Icon, , , &
Pages 1121-1133 | Received 13 Dec 2020, Accepted 15 Apr 2021, Published online: 04 May 2021

References

  • Adeloye D, Chua S, Lee C, et al. Global and regional estimates of COPD prevalence: systematic review and meta-analysis. J Glob Health. 2015;5(2):020415.
  • WHO. Causes of death [Internet]. [cited 2020 Nov 24]. Available from: https://www.who.int/data/maternal-newborn-child-adolescent/monitor.
  • Ye C, Younus A, Malik R, et al. Subclinical cardiovascular disease in patients with chronic obstructive pulmonary disease: a systematic review. QJM. 2017;110(6):341–349.
  • Morgan AD, Zakeri R, Quint JK. Defining the relationship between COPD and CVD: what are the implications for clinical practice? Ther Adv Respir Dis. 2018;12:1753465817750524.
  • Polverino F, Celli BR, Owen CA. COPD as an endothelial disorder: endothelial injury linking lesions in the lungs and other organs? (2017 Grover Conference Series). Pulm Circ. 2018;8(1):2045894018758528.
  • Aird WC. Phenotypic heterogeneity of the endothelium: i. Structure, function, and mechanisms. Circ Res. 2007;100(2):158–173.
  • Flammer AJ, Anderson T, Celermajer DS, et al., The assessment of endothelial function: from research into clinical practice. Circulation. 2012;126(6):753–767.
  • Jourde-Chiche N, Fakhouri F, Dou L, et al. Endothelium structure and function in kidney health and disease. Nat Rev Nephrol. 2019;15:87–108.
  • Lekakis J, Abraham P, Balbarini A, et al., Methods for evaluating endothelial function: a position statement from the European Society of Cardiology working group on peripheral circulation. Eur J Cardiovasc Prev Rehabil. 2011;18(6):775–789.
  • Rodriguez-Miguelez P, Seigler N, Bass L, et al. Assessments of endothelial function and arterial stiffness are reproducible in patients with COPD. Int J Chron Obstruct Pulmon Dis. 2015;10:1977–1986.
  • Louvaris Z, Rodrigues A, Dacha S, et al. High-intensity exercise impairs extradiaphragmatic respiratory muscle perfusion in patients with COPD. J Appl Physiol (1985). 2021;130(2):325–341. .
  • Wilkinson IB, Webb DJ. Venous occlusion plethysmography in cardiovascular research: methodology and clinical applications. Br J Clin Pharmacol. 2001;52(6):631–646.
  • Maruhashi T, Kihara Y, Higashi Y. Assessment of endothelium-independent vasodilation: from methodology to clinical perspectives. J Hypertens. 2018;36(7):1460–1467.
  • Gliemann L, Mortensen SP, Hellsten Y. Methods for the determination of skeletal muscle blood flow: development, strengths and limitations. Eur J Appl Physiol. 2018;118(6):1081–1094.
  • Brunner H, Cockcroft JR, Deanfield J, et al. Endothelial function and dysfunction. Part II: association with cardiovascular risk factors and diseases. A statement by the working group on endothelins and endothelial factors of the European Society of Hypertension. J Hypertens. 2005;23(2):233–246.
  • Deanfield J, Donald A, Ferri C, et al., Endothelial function and dysfunction. Part I: methodological issues for assessment in the different vascular beds: a statement by the working group on Endothelin and Endothelial factors of the European Society of Hypertension. J Hypertens. 2005;23(1):7–17.
  • Maclay JD, McAllister DA, Mills NL, et al. Vascular dysfunction in chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2009;180(6):513–520.
  • Boyer L, Chaar V, Pelle G, et al. Effects of polycythemia on systemic endothelial function in chronic hypoxic lung disease. J Appl Physiol (1985). 2011;110(5):1196–1203.
  • Yang L, Mäki‐Petäjä K, Cheriyan J, et al. The role of epoxyeicosatrienoic acids in the cardiovascular system. Br J Clin Pharmacol. 2015;80(1):28–44.
  • Yang L, Cheriyan J, Gutterman DD, et al. Mechanisms of vascular dysfunction in COPD and effects of a novel soluble epoxide hydrolase inhibitor in smokers. Chest. 2017;151(3):555–563.
  • Raitakari OT, Celermajer DS. Research Methods in Human Cardiovascular Pharmacology edited by Dr S. Maxwell and Prof. D. Webb Flow-mediated dilatation. Br J Clin Pharmacol. 2000;50(5):397–404.
  • Stout M. Flow-mediated dilatation: a review of techniques and applications. Echocardiography. 2009;26(7):832–841.
  • Corretti MC, Anderson TJ, Benjamin EJ, et al. Guidelines for the ultrasound assessment of endothelial-dependent flow-mediated vasodilation of the brachial artery: a report of the international brachial artery reactivity task force. J Am Coll Cardiol. 2002;39:257–265.
  • Pizarro S, García-Lucio J, Peinado VI, et al. Circulating progenitor cells and vascular dysfunction in chronic obstructive pulmonary disease. PloS One. 2014;9(8):e106163. .
  • Anderson TJ, Gerhard MD, Meredith IT, et al. Systemic nature of endothelial dysfunction in atherosclerosis. Am J Cardiol. 1995;75(6):71B–74B. .
  • Eickhoff P, Valipour A, Kiss D, et al., Determinants of systemic vascular function in patients with stable chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2008;178(12):1211–1218.
  • Moro L, Pedone C, Scarlata S, et al. Endothelial dysfunction in chronic obstructive pulmonary disease. Angiology. 2008;59(3):357–364.
  • Blum A, Simsolo C, Sirchan R. Vascular responsiveness in patients with Chronic Obstructive Pulmonary Disease (COPD). Eur J Intern Med. 2014;25(4):370–373.
  • Piccari L, Del Pozo R, Blanco I, et al. Association between systemic and pulmonary vascular dysfunction in COPD. Int J Chron Obstruct Pulmon Dis. 2020;15:2037–2047.
  • Keymel S, Schueller B, Sansone R, et al. Oxygen dependence of endothelium-dependent vasodilation: importance in chronic obstructive pulmonary disease. Arch Med Sci. 2018;14(2):297–306. .
  • Karoli NA, Rebrov AP. Endothelial dysfunction in patients with chronic obstructive pulmonary disease in combination with coronary heart disease. Ter Arkh. 2019;91(3):22–26.
  • Chandra D, Gupta A, Strollo PJ, et al. Airflow limitation and endothelial dysfunction. Unrelated and independent predictors of atherosclerosis. Am J Respir Crit Care Med. 2016;194(1):38–47.
  • Clarenbach CF, Senn O, Sievi NA, et al. Determinants of endothelial function in patients with COPD. Eur Respir J. 2013;42(5):1194–1204. .
  • Urban MH, Valipour A, Kiss D, et al. Soluble receptor of advanced glycation end-products and endothelial dysfunction in COPD. Respir Med. 2014;108(6):891–897. .
  • Barr RG, Mesia-Vela S, Austin JHM, et al. Impaired flow-mediated dilation is associated with low pulmonary function and emphysema in ex-smokers: the Emphysema and Cancer Action Project (EMCAP) study. Am J Respir Crit Care Med. 2007;176(12):1200–1207. .
  • Clarenbach CF, Sievi NA, Kohler M. Annual progression of endothelial dysfunction in patients with COPD. Respir Med. 2017;132:15–20.
  • Ozben B, Eryüksel E, Tanrikulu AM, et al. Acute exacerbation impairs endothelial function in patients with chronic obstructive pulmonary disease. Turk Kardiyol Dern Ars. 2010;38(1):1–7.
  • Marchetti N, Ciccolella DE, Jacobs MR, et al., Hospitalized acute exacerbation of COPD impairs flow and nitroglycerin-mediated peripheral vascular dilation. COPD. 2011;8(2):60–65.
  • De Matthaeis A, Greco A, Dagostino MP, et al. Effects of hypercapnia on peripheral vascular reactivity in elderly patients with acute exacerbation of chronic obstructive pulmonary disease. Clin Interv Aging. 2014;9:871–878.
  • Urban MH, Ay L, Funk GC, et al. Insulin resistance may contribute to vascular dysfunction in patients with chronic obstructive pulmonary disease. Wien Klin Wochenschr. 2014;126(3–4):106–112.
  • Barak OF, Mladinov S, Hoiland RL, et al. Disturbed blood flow worsens endothelial dysfunction in moderate-severe chronic obstructive pulmonary disease. Sci Rep. 2017;7(1):16929. .
  • Da Luz Goulart C, Caruso FR, Garcia De Araújo AS, et al. Non-invasive ventilation improves exercise tolerance and peripheral vascular function after high-intensity exercise in COPD-HF patients. Respir Med. 2020;173:106173.
  • Clarenbach CF, Sievi NA, Brock M, et al. Lung volume reduction surgery and improvement of endothelial function and blood pressure in patients with chronic obstructive pulmonary disease. A randomized controlled trial. Am J Respir Crit Care Med. 2015;192(3):307–314.
  • Rodriguez-Miguelez P, Gregg J, Seigler N, et al. Acute tetrahydrobiopterin improves endothelial function in patients with COPD. Chest. 2018;154(3):597–606.
  • Ives SJ, Harris RA, Witman MAH, et al. Vascular dysfunction and chronic obstructive pulmonary disease: the role of redox balance. Hypertension. 2014;63(3):459–467.
  • Hartmann SE, Waltz X, Leigh R, et al. Blood flow during handgrip exercise in COPD: effect of vitamin C. Med Sci Sports Exerc. 2016;48(2):200–209.
  • Pavitt MJ, Tanner RJ, Lewis A, et al. Oral nitrate supplementation to enhance pulmonary rehabilitation in COPD: ON-EPIC a multicentre, double-blind, placebo-controlled, randomised parallel group study. Thorax. 2020;75(7):547–555.
  • Fisk M, Cheriyan J, Mohan D, et al. The p38 mitogen activated protein kinase inhibitor losmapimod in chronic obstructive pulmonary disease patients with systemic inflammation, stratified by fibrinogen: a randomised double-blind placebo-controlled trial. PLoS One. 2018;13(3):e0194197.
  • Kim JS, Thomashow MA, Yip NH, et al. Randomization to omega-3 fatty acid supplementation and endothelial function in COPD: the COD-Fish randomized controlled trial. Chronic Obstr Pulm Dis. 2021;8(1). DOI:10.15326/jcopdf.8.1.2020.0132
  • Merlo C, Bernardi E, Bellotti F, et al. Supervised exercise training improves endothelial function in COPD patients: a method to reduce cardiovascular risk? ERJ Open Res. 2020;6(2):00304–2019.
  • Gelinas JC, Lewis NC, Harper MI, et al. Aerobic exercise training does not alter vascular structure and function in chronic obstructive pulmonary disease. Exp Physiol. 2017;102(11):1548–1560.
  • Hedetoft M, Olsen NV. Evaluation of endothelial function by peripheral arterial tonometry and relation with the nitric oxide pathway. Nitric Oxide. 2014;42:1–8.
  • Hamburg NM, Keyes MJ, Larson MG, et al. Cross-sectional relations of digital vascular function to cardiovascular risk factors in the framingham heart study. Circulation. 2008;117(19):2467–2474. .
  • Rubinshtein R, Kuvin JT, Soffler M, et al. Assessment of endothelial function by non-invasive peripheral arterial tonometry predicts late cardiovascular adverse events. Eur Heart J. 2010;31(9):1142–1148.
  • Malerba M, Radaeli A, Nardin M, et al. Endothelial dysfunction assessment by noninvasive peripheral arterial tonometry in patients with chronic obstructive pulmonary disease compared with healthy subjects. Clin Respir J. 2018;12(4):1466–1472.
  • Vaes AW, Spruit MA, Theunis J, et al. Peripheral endothelial function is positively associated with maximal aerobic capacity in patients with chronic obstructive pulmonary disease. Respir Med. 2018;142:41–47.
  • Minet C, Vivodtzev I, Tamisier R, et al. Reduced six-minute walking distance, high fat-free-mass index and hypercapnia are associated with endothelial dysfunction in COPD. Respir Physiol Neurobiol. 2012;183(2):128–134. .
  • Scherr A, Schumann DM, Karakioulaki M, et al. Endothelial dysfunction is not a predictor of outcome in chronic obstructive pulmonary disease. Respir Res. 2020;21(1):90. .
  • Neukamm A, Høiseth AD, Einvik G, et al. Rosuvastatin treatment in stable chronic obstructive pulmonary disease (RODEO): a randomized controlled trial. J Intern Med. 2015;278(1):59–67. .
  • Pereira De Araujo CL, Pereira Reinaldo G, Foscarini BG, et al. The effects of pulmonary rehabilitation on endothelial function and arterial stiffness in patients with chronic obstructive pulmonary disease. Physiother Res Int. 2020;25(2):e1820. .
  • Babos L, Járai Z, Nemcsik J. Evaluation of microvascular reactivity with laser Doppler flowmetry in chronic kidney disease. World J Nephrol. 2013;2(3):77–83.
  • Hogas SM, Voroneanu L, Serban DN, et al. Methods and potential biomarkers for the evaluation of endothelial dysfunction in chronic kidney disease: a critical approach. J Am Soc Hypertens. 2010;4(3):116–127. .
  • Roustit M, Cracowski J-L. Assessment of endothelial and neurovascular function in human skin microcirculation. Trends Pharmacol Sci. 2013;34(7):373–384.
  • Kalia YN, Naik A, Garrison J, et al. Iontophoretic drug delivery. Adv Drug Deliv Rev. 2004;56(5):619–658.
  • Low DA, Jones H, Cable NT, et al. Historical reviews of the assessment of human cardiovascular function: interrogation and understanding of the control of skin blood flow. Eur J Appl Physiol. 2020;120(1):1–16.
  • Strisciuglio T, De Luca S, Capuano E, et al. Endothelial dysfunction: its clinical value and methods of assessment. Curr Atheroscler Rep. 2014;16(6):417.
  • Seliger SL, Salimi S, Pierre V, et al. Microvascular endothelial dysfunction is associated with albuminuria and CKD in older adults. BMC Nephrol. 2016;17(1):82.
  • Adamska A, Araszkiewicz A, Pilacinski S, et al. Dermal microvessel density and maturity is closely associated with atherogenic dyslipidemia and accumulation of advanced glycation end products in adult patients with type 1 diabetes. Microvasc Res. 2019;121:46–51.
  • Schmidt-Lucke C, Glattkowski-Schäfer G, Kirchhof C, et al. Incidence of cutaneous vasoactivity in patients with anemia and pulmonary hypoxia. Vasa. 2000;29(2):112–115.
  • Triantafyllou A, Anyfanti P, Pyrpasopoulou A, et al. Capillary rarefaction as an index for the microvascular assessment of hypertensive patients. Curr Hypertens Rep. 2015;17(5):33.
  • Antonios TF, Singer DR, Markandu ND, et al. Structural skin capillary rarefaction in essential hypertension. Hypertension. 1999;33(4):998–1001.
  • Schoina M, Loutradis C, Memmos E, et al. Microcirculatory function deteriorates with advancing stages of chronic kidney disease independently of arterial stiffness and atherosclerosis. Hypertens Res. 2021;44(2):179-187.
  • Serné EH, Gans RO, Ter Maaten JC, et al. Impaired skin capillary recruitment in essential hypertension is caused by both functional and structural capillary rarefaction. Hypertension. 2001;38(2):238–242. .
  • Schoina M, Loutradis C, Theodorakopoulou M, et al. The presence of diabetes mellitus further impairs structural and functional capillary density in patients with chronic kidney disease. Microcirculation. 2020;28(2):e12665. .
  • Soulaidopoulos S, Pagkopoulou E, Katsiki N, et al. Arterial stiffness correlates with progressive nailfold capillary microscopic changes in systemic sclerosis: results from a cross-sectional study. Arthritis Res Ther. 2019;21(1):253.
  • Xia Z, Wang G, Xiao H, et al. Diagnostic value of nailfold videocapillaroscopy in systemic sclerosis secondary pulmonary arterial hypertension: a meta-analysis. Intern Med J. 2018;48(11):1355–1359.
  • Corrado A, Carpagnano GE, Gaudio A, et al. Nailfold capillaroscopic findings in systemic sclerosis related lung fibrosis and in idiopathic lung fibrosis. Joint Bone Spine. 2010;77(6):570–574.
  • Nieuwdorp M, Van Haeften TW, Gouverneur MCLG, et al. Loss of endothelial glycocalyx during acute hyperglycemia coincides with endothelial dysfunction and coagulation activation in vivo. Diabetes. 2006;55(2):480–486.
  • Nieuwdorp M, Meuwese MC, Mooij HL, et al. Measuring endothelial glycocalyx dimensions in humans: a potential novel tool to monitor vascular vulnerability. J Appl Physiol (1985). 2008;104(3):845–852.
  • Liew H, Roberts MA, MacGinley R, et al. Endothelial glycocalyx in health and kidney disease: rising star or false dawn? Nephrology (Carlton). 2017;22(12):940–946.
  • Ikonomidis I, Marinou M, Vlastos D, et al. Effects of varenicline and nicotine replacement therapy on arterial elasticity, endothelial glycocalyx and oxidative stress during a 3-month smoking cessation program. Atherosclerosis. 2017;262:123–130.
  • Broekhuizen LN, Lemkes BA, Mooij HL, et al. Effect of sulodexide on endothelial glycocalyx and vascular permeability in patients with type 2 diabetes mellitus. Diabetologia. 2010;53(12):2646–2655. .
  • Vlahu CA, Lemkes BA, Struijk DG, et al. Damage of the endothelial glycocalyx in dialysis patients. J Am Soc Nephrol. 2012;23(11):1900–1908.
  • Mulders TA, Nieuwdorp M, Stroes ES, et al. Non-invasive assessment of microvascular dysfunction in families with premature coronary artery disease. Int J Cardiol. 2013;168(5):5026–5028.
  • Donati A, Damiani E, Luchetti M, et al. Microcirculatory effects of the transfusion of leukodepleted or non-leukodepleted red blood cells in patients with sepsis: a pilot study. Crit Care. 2014;18(1):R33.
  • Uchimido R, Schmidt EP, Shapiro NI. The glycocalyx: a novel diagnostic and therapeutic target in sepsis. Crit Care. 2019;23(1):16.
  • Cerny V, Astapenko D, Burkovskiy I, et al. Glycocalyx in vivo measurement. Clin Hemorheol Microcirc. 2017;67(3–4):499–503. .
  • Cracowski J-L, Roustit M. Current methods to assess human cutaneous blood flow: an updated focus on laser-Based-Techniques. Microcirculation. 2016;23(5):337–344.
  • Tew GA, Klonizakis M, Crank H, et al. Comparison of laser speckle contrast imaging with laser Doppler for assessing microvascular function. Microvasc Res. 2011;82(3):326–332. .
  • De M Matheus AS, Clemente ELS, De Lourdes Guimarães Rodrigues M, et al. Assessment of microvascular endothelial function in type 1 diabetes using laser speckle contrast imaging. J Diabetes Complicat. 2017;31(4):753–757.
  • Borges JP, Lopes GO, Verri V, et al. A novel effective method for the assessment of microvascular function in male patients with coronary artery disease: a pilot study using laser speckle contrast imaging. Braz J Med Biol Res. 2016;49(10):e5541.
  • Piotrowski L, Urbaniak M, Jedrzejczak B, et al. Note: flow mediated skin fluorescence—A novel technique for evaluation of cutaneous microcirculation. Rev Sci Instrum. 2016;87(3):036111.
  • Katarzynska J, Borkowska A, Czajkowski P, et al. Flow mediated skin fluorescence technique reveals remarkable effect of age on microcirculation and metabolic regulation in type 1 diabetes. Microvasc Res. 2019;124:19–24.
  • Katarzynska J, Cholewinski T, Sieron L, et al. Flowmotion monitored by Flow Mediated Skin Fluorescence (FMSF): a tool for characterization of microcirculatory status. Front Physiol. 2020;11:702.
  • Tarnawska M, Dorniak K, Kaszubowski M, et al. A pilot study with flow mediated skin fluorescence: a novel device to assess microvascular endothelial function in coronary artery disease. Cardiol J. 2018;25(1):120–127.
  • Majewski S, Szewczyk K, Białas AJ, et al. Assessment of microvascular function in vivo using flow mediated skin fluorescence (FMSF) in patients with obstructive lung diseases: a preliminary study. Microvasc Res. 2020;127:103914.
  • Jones S, Chiesa ST, Chaturvedi N, et al. Recent developments in near-infrared spectroscopy (NIRS) for the assessment of local skeletal muscle microvascular function and capacity to utilise oxygen. Artery Res. 2016;16(C):25–33.
  • Dipla K, Triantafyllou A, Koletsos N, et al. Impaired muscle oxygenation and elevated exercise blood pressure in hypertensive patients: links with vascular stiffness. Hypertension. 2017;70(2):444–451.
  • Anyfanti P, Triantafyllidou E, Papadopoulos S, et al. Smoking before isometric exercise amplifies myocardial stress and dysregulates baroreceptor sensitivity and cerebral oxygenation. J Am Soc Hypertens. 2017;11(6):376–384.
  • Dipla K, Triantafyllou A, Grigoriadou I, et al. Impairments in microvascular function and skeletal muscle oxygenation in women with gestational diabetes mellitus: links to cardiovascular disease risk factors. Diabetologia. 2017;60(1):192–201.
  • Waksman R, Torguson R, Spad M-A, et al. The lipid-Rich plaque study of vulnerable plaques and vulnerable patients: study design and rationale. Am Heart J. 2017;192:98–104.
  • Manfredini F, Lamberti N, Malagoni AM, et al. The role of deconditioning in the end-stage renal disease myopathy: physical exercise improves altered resting muscle oxygen consumption. Am J Nephrol. 2015;41(4–5):329–336.
  • Adami A, Cao R, Porszasz J, et al. Reproducibility of NIRS assessment of muscle oxidative capacity in smokers with and without COPD. Respir Physiol Neurobiol. 2017;235:18–26.
  • Zelt JT, Jones JH, Hirai DM, et al. Systemic vascular dysfunction is associated with emphysema burden in mild COPD. Respir Med. 2018;136:29–36.
  • Okamoto T, Kanazawa H, Hirata K, et al. Evaluation of oxygen uptake kinetics and oxygen kinetics of peripheral skeletal muscle during recovery from exercise in patients with chronic obstructive pulmonary disease. Clin Physiol Funct Imaging. 2003;23(5):257–262.
  • Chuang M-L, Lin I-F, Hsieh M-J. More impaired dynamic ventilatory muscle oxygenation in congestive heart failure than in chronic obstructive pulmonary disease. J Clin Med. 2019;8(10):1641.
  • Layec G, Hart CR, Trinity JD, et al. Oxygen delivery and the restoration of the muscle energetic balance following exercise: implications for delayed muscle recovery in patients with COPD. Am J Physiol Endocrinol Metab. 2017;313(1):E94–E104.
  • Kutsuzawa T, Shioya S, Kurita D, et al. Deoxygenated hemoglobin/myoglobin kinetics of forearm muscles from rest to exercise in patients with chronic obstructive pulmonary disease. Tohoku J Exp Med. 2009;217(1):9–15.
  • Louvaris Z, Habazettl H, Asimakos A, et al. Heterogeneity of blood flow and metabolism during exercise in patients with chronic obstructive pulmonary disease. Respir Physiol Neurobiol. 2017;237:42–50.
  • Odagawa J, Sekikawa K, Kawaguchi K, et al. Influence of home-based pulmonary rehabilitation on muscle oxygenation in elderly patients with chronic obstructive pulmonary disease. J Phys Ther Sci. 2009;21(4):301–305.
  • Barberan-Garcia A, Munoz PA, Gimeno-Santos E, et al. Training-induced changes on quadriceps muscle oxygenation measured by near-infrared spectroscopy in healthy subjects and in chronic obstructive pulmonary disease patients. Clin Physiol Funct Imaging. 2019;39(4):284–290.
  • Prieur G, Combret Y, Bonnevie T, et al. Functional electrical stimulation changes muscle oxygenation in patients with chronic obstructive pulmonary disease during moderate-Intensity exercise: a secondary analysis. COPD. 2019;16(1):30–36.
  • Lanza GA, Golino M, Villano A, et al. Cardiac rehabilitation and endothelial function. J Clin Med. 2020;9(8):2487.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.